Diagnosis and radioguided surgery with 111In-pentetreotide in a patient with paraneoplastic Cushing's syndrome due to a bronchial carcinoid.
In a 28-year-old man with Cushing's syndrome, studies investigating a hypophyseal and/or adrenal origin of the disease, including computed tomography and magnetic resonance imaging, were negative. In agreement with reports showing somatostatin receptors on the cell membrane of ectopically secreting ACTH tumours, scintigraphy was performed after intravenous injection of 111 MBq 111In-pentetreotide (OCT). The radiolabelled OCT scan showed a small focal area of intense uptake at the inferior lobe of the right lung. Subsequent radioguided surgery located and defined a small mass (1.8 x 1.4 x 1.6 cm). The probe pinpointed the mass to the right inferior chest lobe, with a tumour/normal tissue count ratio of 6:1 and tumour/hilar normal lymph node ratio of 12:1, thus permitting the complete excision of the tumour to exclude lymph node and/or parietal involvement. A lung carcinoid was diagnosed at histology. The patient is still alive and disease-free 24 months after surgery. 111In-OCT was found to be useful for localizing the ACTH-secreting tumour and also permitted rapid non-invasive differential diagnosis between an ACTH-secreting pituitary adenoma and malignancy causing ectopic ACTH syndrome. This study also showed the clinical usefulness of radioguided surgery in the treatment of bronchial carcinoid.
Mansi
L
L
Institute of Radiological Sciences, II University-Naples, Italy.
Rambaldi
P F
PF
Panza
N
N
Esposito
D
D
Esposito
V
V
Pastore
V
V
D000328:Adult; D001984:Bronchial Neoplasms / Q000000981:diagnostic imaging* / Q000601:surgery; D002276:Carcinoid Tumor / Q000000981:diagnostic imaging* / Q000601:surgery; D003480:Cushing Syndrome / Q000000981:diagnostic imaging / Q000601:surgery*; D006801:Humans; D008297:Male; D011877:Radionuclide Imaging; D013004:Somatostatin / Q000031:analogs & derivatives*
D013004:Somatostatin; C081788:pentetreotide